The Potential Role of Rosmarinic Acid and Sinensetin as α-Amylase Inhibitor: In Silico Study
DOI:
https://doi.org/10.21776/ub.jpacr.2019.008.01.460Keywords:
α-amylase inhibitor, in silico, rosmarinic acid, sinensetinAbstract
The study of natural compound as α-amylase inhibitor has been a concern since the synthetic drugs for the management of type 2 diabetes mellitus have several side effects. The present study was carried out to predict the ability of rosmarinic acid and sinensetin as human α-amylase inhibitor by in silico study. All of the prepared 3D structures were used in the molecular docking by using Hex 8.0.0. The visualization of the molecular interactions of those compounds with human salivary α-amylase or human pancreatic α-amylase was established in the Discovery Studio Client 4.1 software. The result of this study determined that rosmarinic acid and sinensetin bound to the A domain of human pancreatic α-amylase and human salivary α-amylase. Rosmarinic acid-human salivary α-amylase complex was observed to possess high number of hydrogen bonds compared to sinensetin-human salivary α-amylase complex. The similar result was observed in the comparison of rosmarinic acid-human pancreatic α-amylase complex and sinensetin-human pancreatic α-amylase complex. The rosmarinic acid was able to bind the Glu233 of human pancreatic α-amylase. These data suggest rosmarinic acid as a potential inhibitor of human salivary α-amylase and human pancreatic α-amylase. Further experimental evidence is needed to confirm this observation.
Downloads
References
[1] Butterworth, P. J., Warren, F. J., Ellis, P. R., Starch, 2011, 63, 395-405.
[2] Blanco, A., Blanco, G., Medical Biochemistry, 2017, Academic Press, London.
[3] Gerich, J., Int. J. Gen. Med., 2013, 6, 877–895.
[4] Krentz, A. J., Bailey, C. J., Drugs, 2005, 65 (3), 385-411.
[5] Rosak, C., Mertes, G., Diabetes Metab. Syndr. Obes., 2012, 5, 357–367.
[6] McCue, P. P., Shetty, K., Asia Pacific J. Clin. Nutr., 2004, 13 (1), 101–106.
[7] Ali, E., Mohamed, H., Jamshed, M., Siddiqui, A., Ang, L. F., Sadikun, A., Chan, S. H., Tan, S. C., Asmawi, M. Z., Yam, M. F. BMC Complement. Altern. Med.,. 2012, 12 (1), 1-7.
[8] Ngo, Y. L., Chua, L. S., Curr. Enzym Inhib., 2018, 14 (2), 97-103.
[9] Zhu, F., Asada, T., Sato, A., Koi, Y., Nishiwaki, H., Tamura, H., J. Agric. Food Chem., 2014, 62. 885-892.
[10] Kim, G., Park, Y. S., Jin, Y., Park, C., Appl. Microbiol. Biotechnol., 2015, 99, 2083–2092.
[11] Jhong, C., Riyaphan, J., Lin, S., Chia, Y., Weng, C., IUBMB, 2015, 41 (4) , 242–251.
[12] Hamdan, I., Afifi, F., Taha, M. O. Pharmazie, 2004, 59, 799-801.
[13] van der Maarel, M. J. E. C., van der Veen, B., Uitdehaag, J. C. M., Leemhuis, H., Dijkhuizen, L. J. Biotechnol., 2002, 94, 137–155.
[14] Brayer, G. D., Sidhu, G., Maurus, R., Rydberg, E. H., Braun, C., Wang, Y., Nguyen, N. T., Overall, C. M., Withers, S. G., Biochemistry, 2000, 39, 4778–4791.
[15] Brayer, G. D., Luo, Y., Withers, S. G., Protein Sci., 1995, 4, 1730–1742.
[16] Ramasubbu, N., Paloth, V., Luo, Y., Brayer, G. D., Levine, M. J., Acta Cryst., 1996, 435–446.
[17] Madeswaran, A., Asokkumar, K., Umamaheswari, M., Sivashanmugam, T., Subhadradevi, V., Jagannath, P., JCMMD, 2014, 4 (2), 51–56.
[18] de Sales, P. M., de Souza, P. M., Simeoni, L. A., Magalhães, P. D. O., Silveira, D., J. Pharm. Pharmaceut. Sci., 2012, 15 (1), 141–183.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).